v3.26.1
Accrued Expenses and Other Current Liabilities
 12 Months Ended
Dec. 31, 2025
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities

Note 5 – Accrued Expenses and Other Current Liabilities‌

 

Accrued expenses and other current liabilities consisted of the following as of December 31, 2025 and December 31, 2024:

 

   2025   2024 
   For the Years Ended 
   December 31, 
   2025   2024 
         
Payroll accrual  $1,343,382   $1,039,338 
Interest accrual   666,958    268,972 
Bonus accrual   536,500    536,500 
Accrued issuable equity   57,195    - 
Other accrued expenses   -    41,970 
Registration delay liability   7,261    7,261 
Total accrued expenses and other current liabilities  $2,611,296   $1,894,041 

 

 

ZYVERSA THERAPEUTICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS